ClinicalTrials.gg
RecruitingNCT03017118Updated Nov 24, 2025

Turmeric for Patients With Basal Joint Arthritis

An interventional study of Turmeric and Placebo in Thumb Osteoarthritis, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2017; still recruiting 9 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Osteoarthritis by Massachusetts General Hospital — 3 open to participants now, 4 under way, 1 of them phase 3. Osteoarthritis · Massachusetts General Hospital.

Planned enrollment
6th of 10
60 · median 85
Started
2017
the only one that year
No phase
8 of 13
1 open now
Registered
8th of 13
by date

Among the 13 studies in Osteoarthritis by Massachusetts General Hospital, this one is the 6th largest by planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2017, is one of 8 with no phase, and was the 8th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

3 of the 13 studies in Osteoarthritis by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 40 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Osteoarthritis by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.

03

Conditions studied

  • Thumb Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 40 years of age or older
  • English fluency and literacy
  • Seeking care for basal joint pain
  • Tender over basal joint
  • Positive distraction rotation test (rotation of the thumb metacarpal base while applying axial traction)
  • Radiographic evidence of Eaton stage 1 and 2 only

Exclusion criteria

Exclusion Criteria:

  • Secondary gains (litigations or worker compensation) procedures that may interfere with patients' motivation for treatment
  • Inability or unwillingness to participate in a trial study
  • Rheumatoid Arthritis or other inflammatory disorder diagnoses
  • Post-traumatic osteoarthritis
  • Patients on Coumadin//NSAIDs/Tylenol
  • Diabetes Mellitus
  • Pregnant or lactating women
  • Basal joint arthritis of Eaton stage 3
  • Patients seeking other treatment for their basal joint arthritis (splint, corticosteroid injection, surgery)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Turmeric

    Subjects in this group will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.

    Dietary Supplement: Turmeric

  • Placebo comparator
    Control

    Subjects in this group will receive a placebo pill 3 times per day for 6 weeks.

    Other: Placebo

Interventions

06

What researchers measure

Primary outcomes

  1. Change in baseline pain intensity

    0-10 ordinal rating of pain intensity

    Time frame: Enrollment, 6 weeks, and 3 months

  2. Change in baseline disability

    Disability measured by the QuickDASH

    Time frame: Enrollment, 6 weeks, and 3 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2017 (actual). Primary completion is estimated for Dec 2027, 124 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 124 months is above that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 7, 2016
First posted
Jan 11, 2017
StartActual
Aug 9, 2017
Primary completionEst.
Dec 2027
CompletionEst.
Jan 2028
Last update
Nov 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03017118
Responsible party
Neal Chung-Jen Chen (Medical Doctor, Massachusetts General Hospital) — Principal investigator
First posted
Jan 11, 2017
Start date
Aug 9, 2017
Primary completion
Dec 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Nov 24, 2025

Study contacts

Neal Chen, M.D.
Contact
nchen1@mgh.harvard.edu
617-726-4700
Karan Amin, BA
Contact
kamin2@mgh.harvard.edu
Neal Chen, MD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Turmeric extract · Curcuma longa

Start the discussion